discoverIE Group (DSCV) Q2 2027 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 TU earnings summary
14 Oct, 2026Executive summary
H1 organic sales grew 8%, accelerating from 6% in Q1 to 10% in Q2; strong orders and an expanding order book support expectations for good H2 growth.
Full-year adjusted earnings are running ahead of Board expectations, with strong trading momentum driving an earnings upgrade.
Financial highlights
H1 total sales rose 13% at constant exchange rates (CER), including acquisitions, and 14% on a reported basis; organic sales growth was 8%.
Organic orders increased 22% YoY; orders rose 30% at CER.
Good operating cash flow generation continued through H1.
Outlook and guidance
Strong order book supports expectations for good growth in H2; Sensing & Connectivity growth is expected to accelerate in H2.
Full-year adjusted earnings are running ahead of Board expectations, with strong earnings growth expected over last year.
The interim results are scheduled for release on 2 December 2026.
Latest events from discoverIE Group
- Strong sales growth, strategic acquisitions, and ESG leadership drive long-term value.DSCV
Investor presentation - Orders up 31% organically and sales up 10% with acquisitions, outlook remains strong.DSCV
Q1 2027 TU - Strong Q4 growth, robust cash flow, and accretive acquisitions drive a positive outlook.DSCV
H2 2026 - Strong Q4 and full year growth, robust margins, and strategic investments drive future outlook.DSCV
Q4 2026 TU - Q3 sales and orders rose, margins stayed robust, and acquisitions support ongoing growth.DSCV
Q3 2026 TU - Record profits, strong cash flow, and positive outlook driven by Sensing & Connectivity growth.DSCV
H1 2026 - Record 13.8% margin and strong cash flow offset sales decline; S&C orders up 20%.DSCV
H1 2025 - Targeting 15% margin by FY28 and net zero by 2030, with strong growth from innovation and acquisitions.DSCV
CMD 2024 - Record margin and robust cash flow achieved amid strong target market growth and portfolio actions.DSCV
H2 2024